Hepatocyte Growth Factor Suppresses Proinflammatory NFκB Activation through GSK3β Inactivation in Renal Tubular Epithelial Cells
Open Access
- 1 March 2008
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (12) , 7401-7410
- https://doi.org/10.1074/jbc.m710396200
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor κB target genes and induction of apoptosis in chronic lymphocytic leukemia B cellsBlood, 2007
- GLYCOGEN SYNTHASE KINASE 3β AS A TARGET FOR THE THERAPY OF SHOCK AND INFLAMMATIONShock, 2007
- Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and TherapeuticsNeurochemical Research, 2006
- Activation of PI3K–Akt–GSK3β pathway mediates hepatocyte growth factor inhibition of RANTES expression in renal tubular epithelial cellsBiochemical and Biophysical Research Communications, 2005
- Hepatocyte Growth Factor Suppresses Vascular Endothelial Growth Factor-Induced Expression of Endothelial ICAM-1 and VCAM-1 by Inhibiting the Nuclear Factor-κB PathwayCirculation Research, 2005
- Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of actionAmerican Journal of Physiology-Renal Physiology, 2004
- Crossregulation of NF‐κB by the APC/GSK‐3β/β‐catenin pathwayMolecular Carcinogenesis, 2004
- Phosphorylation of serine 276 is essential for p65 NF- B subunit-dependent cellular responsesBiochemical and Biophysical Research Communications, 2003
- Signal transduction through NF-κBImmunology Today, 1998
- Scatter factor is a fibroblast-derived modulator of epithelial cell mobilityNature, 1987